France· FR:61637983
PROLEUKIN 18 millions U.I., poudre pour solution injectable
A aldesleukin product containing aldesleukine, registered in France by IOVANCE BIOTHERAPEUTICS (PAYS-BAS). The same ATC class is registered in 10 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Aldesleukin is registered in 10 of 19 countries.
Countries holding a registration under ATC L03AC01 (aldesleukin), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 6 of them publish a price we can compare per daily dose
Aldesleukin · ATC L03AC01
10 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Germany
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ALDESLEUKINE
- Manufacturer
- IOVANCE BIOTHERAPEUTICS (PAYS-BAS)
- Country
- France (FR)
- ATC code
- L03AC01
- ATC class
- Aldesleukin
- Defined daily dose
- 0.2 mg, P
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009562158671 flacon(s) en verre
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
472 interactions on record for aldesleukin.
Graded by severity as the source publishes them — 46 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Aldesleukin · interactions on record
472 records
- 46 severe
- 411 moderate
- 15 minor
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- CidofovirJ05AB12severe
- DacarbazineL01AX04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Aldesleukin in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesGUNA-IL 2Guna spa
- GermanyProleukin SIovance Biotherapeutics B.V
- FinlandProleukinNovartis Finland Oy
- NorwayProleukin SClinigen
- SpainPROLEUKIN 18 X 10(6) UI POLVO PARA SOLUCION INYECTABLE O PARA PERFUSIONIovance Biotherapeutics B.V.
- BelgiumProleukin 18 10*6 IUNovartis Pharma
- United KingdomProleukin 18million unit powder for solution for injection vialsIovance Biotherapeutics UK SP Ltd
- NetherlandsProleukin 18 x 1.000.000 IE poeder voor oplossing voor injectie of infusieIovance Biotherapeutics B.V.
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Austria · Proleukin
- Germany · Proleukin S
- Spain · Proleukin
- United Kingdom (Northern Ireland) · Proleukin
- Italy · Proleukin
- Netherlands · Proleukin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/22d53f30-f828-45b8-999e-83d1b13c123f GET /v1/drugs/22d53f30-f828-45b8-999e-83d1b13c123f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61637983",
"date_amm": "1989-09-15",
"type_amm": "Procédure de reconnaissance mutuelle",
"numero_ue": null,
"substance": "ALDESLEUKINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour solution injectable",
"voies_administration": "intraveineuse;sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about aldesleukin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.